Skip to main content

The Prevalence of Congenital Anomalies in Europe

Part of the Advances in Experimental Medicine and Biology book series (AEMB,volume 686)

Abstract

EUROCAT (European Surveillance of Congenital Anomalies) is the network of population-based registers of congenital anomaly in Europe, with a common protocol and data quality review, covering 1.5 million annual births in 22 countries. EUROCAT recorded a total prevalence of major congenital anomalies of 23.9 per 1,000 births for 2003–2007. 80% were livebirths. 2.5% of livebirths with congenital anomaly died in the first week of life. 2.0% were stillbirths or fetal deaths from 20 weeks gestation. 17.6% of all cases were terminations of pregnancy following prenatal diagnosis (TOPFA). Thus, congenital anomalies overwhelmingly concern children surviving the early neonatal period, who have important medical, social or educational needs. The prevalence of chromosomal anomalies was 3.6 per 1,000 births, contributing 28% of stillbirths/fetal deaths from 20 weeks gestation with congenital anomaly, and 48% of all TOPFA. Congenital heart defects (CHD) were the most common non-chromosomal subgroup, at 6.5 per 1,000 births, followed by limb defects (3.8 per 1,000), anomalies of urinary system (3.1 per 1,000) and nervous system defects (2.3 per 1,000). In 2004, perinatal mortality associated with congenital anomaly was 0.93 per 1,000 births, and TOPFA 4.4 per 1,000 births, with considerable country variation. Primary prevention of congenital anomalies in the population based on controlling environmental risk factors is a crucial policy priority, including preconceptional care and whole population approaches.

Keywords

  • Congenital anomalies
  • Prevalence
  • Registers
  • Perinatal mortality

This is a preview of subscription content, access via your institution.

References

  1. Abramsky L, Dolk H and a EUROCAT Folic Acid Working Group (2007) Should Europe fortify a staple food with folic acid? Lancet 369:641–642

    PubMed  CrossRef  Google Scholar 

  2. Abramsky L, Busby A, Dolk H (2005) Promotion of perinconceptional folic acid has had limited success. J R Soc Promot Health 125(5):206–208

    PubMed  CrossRef  Google Scholar 

  3. Bianchi F, Bianca S, Linzalone N, Madeddu A (2004) Surveillance of congenital malformations in Italy: an investigation in the province of Siracusa. Epidemiol Prev 28(2):87–93

    PubMed  Google Scholar 

  4. Bove F, Shim Y, Zeitz P (2002). Drinking water contaminants and adverse pregnancy outcomes: a review. Environ Health Perspect 110(Suppl 1):61–74

    PubMed  Google Scholar 

  5. Boyd PA, de Vigan C, Khoshnood B, Loane M, Garne E, Dolk H and the EUROCAT Working Group (2008) “Survey of Prenatal Screening Policies in Europe for Structural Malformations and Chromosomal Anomalies, and Their Impact on Detection and Termination Rates for Neural Tube Defects and Down’s Syndrome”, BJOG 115:689–696

    PubMed  CrossRef  CAS  Google Scholar 

  6. Busby A, Armstrong B, Dolk H, Armstrong N, Haeusler M, Berghold A, Gillerot Y, Baguette A, Gjergja R, Barisic I, Christiansen M, Goujard J, Steinbicker V, Roesch C, McDonnell R, Scarano G, Calzolari E, Neville A, Cocchi G, Bianca S, Gatt M, de Walle H, Braz P, Latos-Bielenska A, Gener B, Portillo I, Addor M-C, Abramsky L, Ritvanen A, Robert-Gnansia E, Daltveit, A, Aneren G, Ollars B, Edwards G (2005a) Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20(3):393–402

    PubMed  CrossRef  CAS  Google Scholar 

  7. Busby A, Abramsky L, Dolk H, Armstrong B and a EUROCAT Folic Acid Working Group (2005b) Preventing neural tube defects in Europe: population based study. Br Med J 330:574–575

    CrossRef  Google Scholar 

  8. Calzolari E, Bianchi F, Rubini M, Ritvanen A, Neville A and a EUROCAT Working Group (2004) Epidemiology of cleft palate in Europe: implications for genetic research strategy. Cleft Palate Craniofac J 41(3):244–249

    PubMed  CrossRef  Google Scholar 

  9. Cordier S, Bergeret A, Goujard J, Ha M-C, Ayme S, Bianchi F, Calzolari E, De Walle H, Knill-Jones R, Candela S, Dale I, Danaché B, De Vigan C, Fevotte J, Kiel G, Mandereau L, for the Occupational Exposure and Congenital Malformations Working Group (1997) Congenital malformations and maternal occupational exposure to glycol ethers. Epidemiology 8(4):355–363

    PubMed  CrossRef  CAS  Google Scholar 

  10. Dadvand P, Rankin J, Shirley MD, Rushton S, Pless-Mulloli T (2009) Descriptive epidemiology of congenital heart diseases in Northern England. Paediatr Perinatal Epidemiol 23:58–65

    CrossRef  Google Scholar 

  11. De Walle HE, de Jong van den Berg LT (2007) Growing gap in folic acid intake with respect to level of education in the Netherlands. Commun Genet 10:93–6

    CrossRef  Google Scholar 

  12. De Wals P et al (2007) Reduction in neural tube defects after folic acid fortification in Canada. N Engl J Med 357:135–42

    PubMed  CrossRef  Google Scholar 

  13. Dolk H (2005) EUROCAT:25 years of European surveillance of congenital anomalies. Arch Dis Child 90:F355–8

    CrossRef  CAS  Google Scholar 

  14. Dolk H and EUROCAT Project Management Committee (2009) What is the primary prevention of congenital anomalies? Lancet 374:378

    Google Scholar 

  15. Dolk H, Loane M, Garne E, de Walle, H, Queisser-LuftA, de Vigan C, Addor M-C, Gener B, Haeusler M, Jordan H, Tucker D, Stoll C, Feijoo M, Lillis D, Bianchi F (2005a) Trends and geographic inequalities in the livebirth prevalence of Down Syndrome in Europe 1980–1999. Revues Epidem Sante Publique 53:2S87–2S95

    Google Scholar 

  16. Dolk H, Vrijheid, Scott JES, Addor MC, Botting B, de Vigan C, de Walle H, Garne E, Loane M, Pierini A, Garcia-Minaur S, Physick N, Tenconi R, Wiesel A, Calzolari E, Stone D (2004) Towards the effective surveillance of hypospadias. Environ Health Perspect 112(3):398–402

    PubMed  CrossRef  Google Scholar 

  17. ESCO 2009. ESCO Report on Analysis of Risks and Benefits of Fortification of Food with Folic Acid. European Food Safety Authority 2009. http://www.efsa.europa.eu/en/scdocs/doc/sco_esco_wg_folic_acid_report_en.pdf

  18. EUGLOREH 2007 (2009) Chapter 9.1.2 Congenital malformations. In: The Status of Health in the European Union: Towards a Healthier Europe, EU Public Health Programme Project, Global Report on the Health Status in the European Union [http://www.eugloreh.it/ActionPagina_993.do]

  19. EUROCAT (2009) http://www.eurocat-network.eu/ACCESSPREVALENCEDATA/PrevalenceTables. Data uploaded 07/12/2009

  20. EUROCAT Working Group (2009). EUROCAT Special Report: Congenital Heart Defects in Europe 2000–2005. [http://www.eurocat-network.eu/content/Special-Report-CHD.pdf]

  21. EUROCAT (2009c). EUROCAT Statistical Monitoring Report – 2006. http://www.eurocat-network.eu/CLUSTERSAndTRENDS/StatisticalMonitoring/StatisticalMonitoring-2006

  22. EUROCAT (2008) EUROCAT Statistical Monitoring Protocol. http://www.eurocat-network.eu/content/Stat-Mon-Protocol-(April-2008)-2006.pdf

  23. EUROCAT (2006) Using capture–recapture methods to ascertain the completeness of a register, 2nd edn. http://www.eurocat-network.eu/content/Special-Report-Capture-Recapture.pdf

  24. EUROCAT (2005a) EUROCAT Guide 1.3: Instruction for the registration of congenital anomalies. EUROCAT Central Registry, University of Ulster [http://www.eurocat-network.eu/ABOUTUS/DataCollection/GuidelinesforRegistration/Guide1_3InstructionManual

  25. EUROCAT (2005b) EUROCAT Special Report: Prenatal screening policies in Europe. EUROCAT Central Registry, University of Ulster [http://www.eurocat-network.eu/content/Special-Report-Prenatal-Diagnosis.pdf]

  26. EUROCAT (2005c) EUROCAT Special Report: Prevention of neural tube defects by periconceptional folic acid supplementation in Europe. EUROCAT Central Registry, University of Ulster [http://www.eurocat-network.eu/PREVENTIONAndRISKFACTORS/FolicAcid/FolicAcidSpecialReports]

  27. EUROCAT (2002) EUROCAT Special Report: EUROCAT and orofacial clefts: the epidemiology of orofacial clefts in 30 European regions. EUROCAT Central Registry, University of Ulster; University of Ferrara, Italy and the CNR Institute of Clinical Physiology, Pisa, Italy [http://www.eurocat-network.eu/content/Special-Report-Orofacial-Clefts.pdf]

  28. EUROCAT Working Group (1991) Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980–1986. J Epidemiol Commun Health 45(1):52–58

    CrossRef  Google Scholar 

  29. EURO-PERISTAT Project, with SCPE, EUROCAT, EURONEOSTAT, (2008) European Perinatal Health Report. Chapter 9: Congenital Anomalies: EUROCAT. Available: http://www.europeristat.com

  30. Fraser FC (1976) The multifactorial threshold concept – uses and misuses. Teratology 14:267–280

    PubMed  CrossRef  CAS  Google Scholar 

  31. Garne E, Loane M, Dolk H, de Vigan C, Scarano G, Tucker D, Stoll C et al (2005) Prenatal diagnosis of congenital malformations in Europe. Ultrasound Obstet Gynecol 25:6–11

    PubMed  CrossRef  CAS  Google Scholar 

  32. Garne E, Loane M, de Vigan C et al (2004) Prenatal diagnostic procedures in pregnancies with congenital malformations in 14 regions of Europe. Prenat Diagn 24:908–12

    PubMed  CrossRef  Google Scholar 

  33. Garne E, Loane M, Wellesley D, Barisic I and a EUROCAT Working Group (2009) Congenital Hydronephrosis: Prenatal Diagnosis and Epidemiology in Europe. J Pediatr Urol 5:47–52

    PubMed  CrossRef  Google Scholar 

  34. Hansen M, Bower C, Milne E, de Klerk N and Kurinczuk JJ (2005) Assisted reproductive technologies and the risk of birth defects – a systematic review. Hum Reprod 20:328–38

    PubMed  CrossRef  Google Scholar 

  35. Jenkins KJ, Correa A, Feinstein JA et al (2007). Non-inherited risk factors and congenital cardioavascular defects: current knowledge. Circulation 115:2995–3014

    PubMed  CrossRef  Google Scholar 

  36. Loane M, Dolk H, Bradbury and a EUROCAT Working Group (2007) Increasing prevalence of gastroschisis in Europe 1980–2002: A phenomenon restricted to younger mothers? Paediatr Perinatal Epidemiol 21:363–369

    CrossRef  Google Scholar 

  37. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–7

    CrossRef  Google Scholar 

  38. Torfs CP, Christianson RE (1999) Maternal risk factors and major associated defects in infants with Down Syndrome. Epidemiology 10:264–70

    PubMed  CrossRef  CAS  Google Scholar 

  39. Vrijheid M (2000) Health effects of residence near hazardous waste landfill sites: a review of epidemiological literature. Environ Health Perspect Suppl 108(Suppl 1), 101–112

    Google Scholar 

  40. Wellesley D, Boyd P, Dolk H, Pattenden S (2005) An aetiological classification of birth defects for epidemiological research. J Med Genet 42(1), 54–7

    PubMed  CrossRef  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helen Dolk .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2010 Springer Netherlands

About this chapter

Cite this chapter

Dolk, H., Loane, M., Garne, E. (2010). The Prevalence of Congenital Anomalies in Europe. In: Posada de la Paz, M., Groft, S. (eds) Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology, vol 686. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9485-8_20

Download citation